novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Pela melhoria do tratamento da insuficiência cardíaca em Portugal – documento de consenso

26 Janeiro 2017

5 anos Challenges in Cardiology

5 Dezembro 2016
0

Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/ or atrial fibrillation

26 Janeiro 2017
0

-->